FDA Roundup: Oncology Drug Approvals in 2026 Cancer Therapy Advisor FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT March Roundup of FDA Approvals in Oncology: 4 Decisions to Know OncLive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York